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Glucose-mediated induction of TGF-1 and MCP-1 in meso- Peritoneal dialysis solutions using glucose as the os-
thelial cells in vitro is osmolality and polyol pathway dependent. motic agent have been used as an effective treatment for
Background. Glucose is converted to sorbitol and then to patients with end-stage renal disease (ESRD) for morefructose via the polyol pathway that has been implicated in
than two decades. Loss of peritoneal function is still athe pathogenesis of organ damage. The contribution of the
major complication associated with long-term peritonealpolyol pathway to mesothelial cell activation has, however, not
been fully determined. dialysis [1].
Methods. The effect of increasing glucose concentrations Although it is widely assumed that exposure of the
on transforming growth factor-1 (TGF-1) and monocyte peritoneal membrane to the high glucose concentrationschemoattractant protein-1 (MCP-1) secretion by human perito-
contributes to the structural and functional changes [2, 3],neal mesothelial cells (HPMC) was examined. The importance
the precise role of glucose in the pathogenesis of long-of the polyol pathway was identified by its specific inhibition
with an aldose reductase inhibitor. term changes in the peritoneal membrane remains to be
Results. Incubation of HPMC with 5 to 100 mmol/L glucose fully delineated. Histologic data suggest that the structural
resulted in an induction of aldose reductase mRNA and intra-
changes that are observed in long-term peritoneal dialysiscellular sorbitol accumulation accompanied by the induction of
are similar to those observed in diabetic patients withTGF-1 and MCP-1 mRNA expression and protein secretion.
Mannitol at the same concentrations also induced aldose reduc- microangiopathy and include basement membrane redu-
tase, TGF-1 and MCP-1 mRNA and protein expression but at plication, vasculopathy, and the deposition of advanced
a lower level than glucose. Sorbinil dose-dependently reduced glycation end products within peritoneal tissues [4–8].
both intracellular sorbitol levels (79.8% reduction of 60 mmol/L
It has been previously demonstrated that acute expo-d-glucose induced intracellular sorbitol with 100 mol/L sor-
sure to the components of conventional peritoneal dial-binil (N 3, P 0.01) and glucose-induced TGF-1 and MCP-1
secretion. Mannitol induced TGF-1 and MCP-1 secretion was ysis solutions, including glucose, its associated hyper-
not reduced by sorbinil. The addition of 15 to 40 mmol/L osmolality, high lactate concentrations, low pH, and the
sodium lactate, either alone or in the presence of d-glucose presence of glucose degradation products, inhibits manyenhanced TGF-1 and MCP-1 secretion, which was inhibited
cell functions [9]. Much less is known, however, aboutby sorbinil. In contrast, sodium pyruvate appeared to antago-
the potential of these components to activate cellularnize d-glucose–induced TGF-1 and MCP-1 secretion.
Conclusion. These data suggest that the polyol pathway and responses related to peritoneal inflammation and fibrosis
osmolality contribute to the regulation of HPMC function by [8]. Previous studies have identified that the mesothelium
glucose. Control of polyol pathway activation might reduce plays a pivotal role in the control of peritoneal inflam-glucose-mediated damage to the peritoneal membrane and
mation and homeostasis and thus may be a prime targetpromote its long-term survival.
for the action of dialysis fluid components such as glucose
[10, 11]. Initial experiments by Kumano et al [12] were
the first to suggest that high concentrations of glucose
were capable of activating rat mesothelial cell fibronectin
mRNA expression. This effect was apparently indepen-
dent of osmolality, data confirmed by Kang et al [13],Key words: polyol pathway, glucose, TGF-1, MCP-1, human perito-
neal mesothelial cell, peritoneal membrane function, osmolality. suggesting that glucose alone, or in combination with spent
dialysate, can activate human peritoneal mesothelial cellReceived for publication August 5, 2002
(HPMC) transforming growth factor-1 (TGF-1) mRNAand in revised form September 18, 2002, and October 21, 2002
Accepted for publication November 26, 2002 expression and synthesis. Other studies, however, have
suggested that both osmolality-dependent and indepen- 2003 by the International Society of Nephrology
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dent inhibitory effects of glucose on proliferation, mor- METHODS
phology, and matrix metalloproteinase (MMP9) expression HPMC culture
occur in mesothelial cells [14]. The precise mechanisms HPMC, obtained from the omental tissue of consenting
controlling HPMC activation by glucose, and the defini- patients undergoing elective abdominal surgery, were
tion of whether the metabolic or osmolality-driven effects isolated and characterized as described previously [27].
of glucose are most important, therefore, remain to be The cells cultured were pure mesothelial cells as assessed
fully determined. by their uniform cobblestone appearance at confluence,
The polyol pathway is a hyperglycemia-driven path- by the presence of surface microvilli, by the lack of stain-
way involved in the conversion of glucose to sorbitol by ing for factor VIII related antigen, and by the uniform
the enzyme aldose reductase and then to fructose by the positive staining for cytokeratins 8 and 18. Cells were
enzyme sorbitol dehydrogenase. The activation of aldose maintained in M199 medium (ICN Biomedicals, Ltd.,
reductase, the rate-limiting enzyme, by increasing glu- High Wycombe, Bucks, UK) supplemented with 100 U/mL
cose concentrations, has been widely implicated in the penicillin, 10 mg/mL streptomycin, 2 mmol/L l-gluta-
pathogenesis of diabetic complications in various organs, mine (Life Technologies, Ltd., Uxbridge, UK), 5 g/mL
especially in the eye and the kidney [15–18]. Much less transferrin, 5 g/mL insulin, 0.4 g/mL hydrocortisone
is known about polyol pathway activation in the context (Sigma-Aldrich, Ltd., Poole, UK) and 10% v/v fetal calf
of the dialyzed peritoneal cavity. The relationship be- serum (FCS) (ICN Biomedicals Ltd.). Cells were passaged
tween glucose, osmolality, and cell activation is compli- using trypsin/ethylenediaminetetraacetic acid (EDTA)
cated by the fact that the latter can also act as a polyol (0.125% w/v: 0.01% w/v) (Life Technologies, Ltd.).
pathway activator. In several cell lines, including rat aor- HPMCs were grown to confluence in 6- or 24-multiwell
plates and then changed to 0.1% v/v FCS rest mediumtic smooth muscle cells and rat medullary cells, the polyol
for 48 hours for growth arrest prior to stimulation. Allpathway is activated by hyperosmolality, resulting in an
experiments were performed at 0.1% v/v medium asup-regulation of the aldose reductase gene expression
previous studies had identified that under these condi-[19–21].
tions cells were maintained in a quiescent but viable stateLactate, which is present in conventional dialysis solu-
for extended time periods [28].tions at high concentrations, can also modulate glucose-
mediated effects on cell function (abstract; Kaur D et al,
HPMC activation experimentsJ Am Soc Nephrol 8:266A, 1997). While the precise mech-
d-Glucose, mannitol, sorbitol, l-sodium lactate, so-anism by which this occurs (in the absence of low pH)
dium pyruvate, and sodium chloride (NaCl) were pur-has not been fully identified, there is evidence that lactate
chased from Sigma-Aldrich, Ltd. The aldose reductasemodulates cell function by accelerating glucose-driven
inhibitor Sorbinil was a gift from Pfizer Central Re-intracellular sorbitol accumulation [22, 23].
search (Pfizer, Inc., Groton, CT, USA).The peritoneum of peritoneal dialysis patients is con-
To examine the effect of glucose on activation of thestantly exposed to glucose concentrations far in excess
polyol pathway and TGF-1 and MCP-1 secretion, HPMCof those found in diabetic plasma, hyperosmolality, and
were incubated with increasing d-glucose concentrationssupraphysiologic levels of lactate. The processes of in-
(5 to 100 mol/L) using mannitol or NaCl as osmotic con-
flammation and ongoing fibrosis appear to contribute
trols. Intracellular sorbitol concentrations, aldose reduc-
centrally to membrane dysfunction in peritoneal dialysis tase and sorbitol dehydrogenase mRNA, TGF-1 and
[7, 24]. Centrally involved in this process are mediators MCP-1 mRNA and protein levels in the supernatants were
important in chronic leukocyte recruitment [such as mono- quantitated. In additional experiments to examine the
cyte chemoattractant protein-1 (MCP-1)] and factors im- role of polyol pathway in TGF-1 and MCP-1 secretion,
portant in driving the fibrotic process (e.g., TGF-1 and HPMCs were treated with d-glucose, mannitol, or NaCl
other growth factors). In the current study, we have in the presence of increasing Sorbinil concentrations (0 to
examined its impact on the secretion of TGF-1—a 100 mol/L). These concentrations of Sorbinil were not
growth factor centrally implicated in the fibrotic process cytotoxic to HPMC as assessed by measurements of total
and MCP-1—a chemotactic cytokine known to be impor- cellular adenosine triphosphate (ATP) (control, 63.35 
tant in the control of mononuclear leukocyte recruitment 7.8 relative light units (RLU)/105 HPMC; 100 mol/L
into the peritoneal cavity during inflammation [25, 26]. Sorbinil, 67.14  8.7 RLU/105 HPMC. Concentrations
Our data suggest that glucose-mediated up-regulation above 100 mol/L were not used as these were found
of HPMC TGF-1 and MCP-1 synthesis is both polyol to reduce the viability of growth arrested HPMC [250
pathway and osmolality dependent and is promoted by mol/L, 57.5 7.8 RLU/105 HPMC (90.76% of control)].
the presence of lactate at concentrations present in con- To examine the effect of sodium lactate and sodium
pyruvate on TGF-1 and MCP-1 secretion, HPMCs wereventional peritoneal dialysis solutions.
Wong et al: Polyol pathway activation and HPMC function1406
incubated with 15 mmol/L or 40 mmol/L sodium lactate 250 units, 5 U/L] using a Perkin-Elmer Gene Amp
System 9700 Thermocycler (Applied Biosystems, Ltd.,or sodium pyruvate (pH 7.4) or NaCl as the osmotic con-
trol. In parallel experiments Sorbinil (0 to 100 mol/L) Warrington, UK). The PCR protocol was as follows: first
cycle, 94C for 10 minutes and 72C for 10 minutes;was added to examine the effect of polyol pathway inhi-
bition on sodium lactate–induced TGF-1 and MCP-1 second cycle, 94C for 3 minutes, 55C for 1 minute, and
then 72C for 1 minute; third cycle (nth cycles), 94C forsecretion.
40 seconds, 55C for 1 minute, and 72C for 1 minute.
Cell viability (total cellular ATP measurements) The final stage was 94C for 40 seconds and 60C for 10
minutes. PCR was performed for 24 cycles for -actin, 23Cells were grown to confluency in 96-well or 24-well
plates and growth arrested for 48 hours as previously cycles for MCP-1, and 28 cycles for aldose reductase and
sorbitol dehydrogenase and TGF-1. One tenth of thedescribed. Test solutions ( inhibitors) were added for
the prescribed experimental design and after removal of PCR reaction product from both test and control (-actin)
product were mixed and separated by flat bed electro-supernatants total cellular ATP was assessed as pre-
viously described [29]. Briefly, BAC extract (1 mg/mL phoresis in 3% weight/volume with NuSieve GTG aga-
rose gels (Flowgen Instruments, Ltd., Sittingbourne,benzylkonium chloride in 10 mmol/L EDTA; pH 6.8)
was added to the cell layer to extract ATP. N-2 hydroxy- UK), stained with ethidium bromide (Sigma-Aldrich,
Ltd.), and photographed. The negatives were scanned withethylpiperazine-N-2-ethanesulfonic acid (HEPES) (25
mmol/L)/10 mmol/L EDTA; pH 6.8 was added to stabi- a densitometer (Model 620 video densitometer; Bio-Rad
Laboratories, Ltd., Milton Keynes, UK) and the densitylize the extracted ATP. The ATP content was measured
by adding 25 L firefly bioluminescence reagent (ATP of the bands compared to those of the housekeeping
gene. Results were expressed as product/-actin mRNABioluminescence CLS Reagent, Boehringer-Mannheim,
Mannheim, Germany) to 25 L extracted sample and ratios. The sequences of the amplification primers are
as follows:the light output measured using a Dynex/MLX micro-
titerplate luminometer (Dynex, Ltd., Billinghurst, UK). Aldose reductase (product size 411 bp): forward, 5-
CAA CAA CGG CGC CAA GAT GC; reverse, 5-There is direct correlation between RLU and ATP con-
centration determined using the internal ATP standard GCC GCC CAC GTG TCC AGA A [31]
Sorbitol dehydrogenase (product size 318 bp): for-supplied (y  13610x0.472, r  0.992).
ward, 5-GGG ACT TGC GCC TGG AGA ACT; re-
Assessment of changes in mRNA expression verse, 5-GGG GCG TGG CAC AGA AGA AGA [32]
TGF-1 (product size 288 bp): forward, 5-ACC GGCTo study the effect of glucose on aldose reductase,
sorbitol dehydrogenase, TGF-1, and MCP-1 mRNA CTT CCT GCT CCT CA; reverse, 5-CGC CCG GGT
TGT GCT GGT TGT [33]expression, growth-arrested HPMCs were incubated with
d-glucose or mannitol (5 to 100 mmol/L) as control for MCP-1 (product size 369 bp): forward, 5-TCGCCT
CCAGCATGAAAGTCT; reverse, 5-TCGCCTCCAtime periods up to 144 hours. Total cellular RNA was
extracted with RNA Isolator (Genosys Biotechnologies, GCATGAAAGTCT [34]
-actin (product size 204 bp): forward, 5-GGA GCAInc., Cambridge, UK) as per manufacturer’s instructions.
Total RNA was isolated and subsequently reversed tran- ATG ATC TTG ATC TT; reverse, 5-CCT TCC TGG
GCA TGG AGT CCT [35]scribed into cDNA using the random hexamers method
as previously described [30]. The reaction mixture con- That real increases in TGF-1 mRNA occurred was
confirmed by competitive PCR using the PCR MIMICtained 1L random hexamers (hexadeoxyribonucleotides,
pd[N]6 (Amersham Pharmacia Biotech, Inc., Amersham, Construction Kit (Clontech Laboratories, Ltd., Cambridge
Bioscience, Cambridge, UK) as previously described [27].UK), 5 L nucleotide triphosphate (NTP) (mixed nucle-
otides, dATP, dCTP, dGTP, dTTP) (Gibco/BRL, Life After purification the equal amounts of target cDNA
derived from experimental RNA were PCR amplifiedTechnologies, Ltd.), 2 L 10 	 polymerase chain reac-
tion (PCR) buffer (with 15 mmol/L MgCl2) (Perkin-El- in the presence of twofold serial dilutions of the TGF-
MIMIC. The PCR products were resolved on the agarosemer; Warrington, UK), 2L dithiothreitol (DTT) (Gibco/
BRL), 1 L RNAase inhibitor (RNAsin 40 units/L (Pro- gels and the optical density of the bands was measured
as described previously. Then the ratio of the TGF-1mega, Ltd., Southampton, UK), 1L reverse transcriptase
(200 units/L) (SuperscriptTM RT; GibcoBRL/Life Tech- target to the interleukin-6 (IL-6) MIMIC products was
calculated and graphed as a function of the TGF-1nologies, Ltd.), and 1 g total RNA. PCR amplification
was performed in a total volume of 50 L [2 L reverse MIMIC concentration. From the standard curve gener-
ated in this manner the initial amount of TGF-1 targettranscription (RT) product and 48 L master mix (36.25 L
water, 1.25 L 5-primer (20 mol/L), 1.25 L 3-primer cDNA was determined by extrapolating from the point
where the amounts of the experimental cDNA and the(20 mol/L), 4 L NTP, 5 L 10 	 PCR buffer, and 0.25
L Taq polymerase (Amplitaq GoldTM; Perkin-Elmer MIMIC cDNA reached equivalence. After the correc-
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tion for the difference in size between the TGF-1 target TGF-1 mRNA expression (Fig. 1A). Although there
was significant constitutive expression in 5 mmol/L d-glu-and the TGF-1 MIMIC products the concentration of
mRNA in the original sample was estimated. The com- cose, in 60 mmol/L d-glucose expression increased with
time and was maximally induced between 24 and 48 hoursposite primer sequences were as follows:
TGF-1-MIMIC-Forward (41mer) (41.7%  26% increase at 24 hours). Exposure of HPMC
to increasing concentrations of d-glucose (5 to 100 mmol/L)5-acc ggc ctt tcc tgc ttc tca--cag ccg tcc caa gtt tcg tg-3
TGF-1-MIMIC-Reverse (41mer) for 24 hours resulted in a dose-dependent induction of
TGF-1 mRNA. This was maximal at 100 mmol/L d-glu-5-cgc ccg ggt tat gct ggt tgt--gtg ccc ctg ccc att tct gt-3
cose when expression (expressed as TGF-1/-actin ratio)
Measurement of intracellular sorbitol concentration was increased by 42%  12% (Fig. 1B). That these
qualitative increases detected by RT-PCR were real wasAfter defined stimulation periods HPMC were lyzed
confirmed by quantitative PCR. The amount of TGF-1by addition of 500 L 0.1% v/v Triton x-100 (Sigma-
mRNA increased from 751 136 (fmol/L/g total RNA)Aldrich, Ltd.). Samples were centrifuged for 6 minutes
in control to 1699  430 (fmol/L/g total RNA) inat 13,000 rpm to remove cell debris and stored at 
70C
HPMC incubated with 60 mmol/L d-glucose for 24 hoursprior to assay. Intracellular sorbitol concentrations were
(mean  SEM, N  3, P  0.05). Incubation of growthdetermined using the d-Sorbitol Assay Kit (Boehringer
arrested HPMC with mannitol (5 to 60 mmol/L) resultedMannheim, Lewes, UK) as per manufacturer’s instruc-
in a small but not significant increase in TGF-1 mRNAtions. In the assay sorbitol is oxidized by nicotinamide
expression (data not shown).adenine dinucleotide (NAD) to fructose in the presence
of sorbitol dehydrogenase forming NADH. Subsequently,
Effect of D-glucose on TGF-1 secretion by HPMCNADH reduces iodonitrotetrazolium (INT) to form a
formazan in the presence of diaphorase, which is mea- When incubated for 48 hours with glucose (5 to 100
mmol/L), a dose-dependent increase in TGF-1 secre-sured at 490 nm in a MR5000 microplate spectrometer
(Dynex Ltd., Billinghurst, UK). Intracellular sorbitol tion was observed. TGF-1 levels (expressed as pg/105
HPMC) were 273  14, 422  22, and 609  41 for 5concentrations could not be measured in the presence
of mannitol or sodium lactate as both interfered with the mmol/L, 40 mmol/L, and 100 mmol/L d-glucose, respec-
tively (N  3, P  0.05 for all) (Fig. 1C). This inductionassay (manufacturers’ instructions and data not shown).
was also time dependent. TGF-1 secretion (d-glucose,
MCP-1 and TGF-1 protein measurements 60 mmol/L) became significant after 12 hours (49  32
pg/105 HPMC) and was sustained over the whole timeTGF-1 and MCP-1 concentration in the culture su-
course measured (631 56 pg/105 HPMC after 48 hours)pernatant was determined by specific enzyme-linked im-
(Fig. 1D). When HPMC were incubated with mannitol,munoassay (ELISA) using paired antibodies (TGF-1
a similar, but overall lower in magnitude, time- and dose-ELISA from Duoset, R&D Systems, Oxford, UK; and
dependent increase in TGF-1 secretion was observed.MCP-1 ELISA from OptEIATM, Pharmingen Becton
Dickinson, Oxford, UK) as per manufacturer’s instruc- TGF-1 levels were significantly elevated above control
tions. Total TGF-1 was measured after acidification at concentrations above 60 mmol/L; 403 36 and increased
with 0.1 N HCl and neutralization with 0.1 N NaOH. to 481  34, at 100 mmol/L mannitol (N  3, P  0.05
All the TGF-1 and MCP-1 values were corrected for vs. control for both). After 48 hours, TGF-1 induction
the number of HPMC assessed by direct cell counting. was significantly higher in glucose-treated HPMC com-
pared to those treated with mannitol (N  3, P  0.05)
Statistical analysis (Fig. 1 C and D).
Results are expressed as the mean  SEM of three to
Effect of D-glucose on MCP-1 mRNA expressionseven experiments, with HPMC isolated from different
by HPMCdonors. Statistical analysis between treatments was per-
formed using the paired Student t test (two-tailed) (SPSS Exposure of HPMC to increasing concentrations of
10 for Macintosh, SPSS, Inc.). Differences were consid- d-glucose or mannitol (5 to 100 mmol/L) resulted in a
ered significant when P  0.05. dose-dependent induction of MCP-1 mRNA expression
(Fig. 2A). This induction was maximal at a d-glucose or
mannitol concentration of 60 mmol/L, when expression
RESULTS
(expressed as MCP-1/-actin ratio) was increased by
Effect of D-glucose on TGF-1 mRNA expression 3.29- and 2.36-fold versus 5 mmol/L d-glucose control
for 60 mmol/L d-glucose and 60 mmol/L mannitol, respec-Incubation of growth arrested HPMC with d-glucose
(60 mmol/L) resulted in a time-dependent induction of tively (N  3, P  0.05 for control for both) (Fig. 2B).
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Fig. 1. Time course of transforming growth factor-1 (TGF-1) mRNA expression as assessed by reverse transcription-polymerase chain reaction
(RT-PCR) in growth-arrested human peritoneal mesothelial cells (HPMCs) exposed to 60 mmol/L D-glucose. (A) Top panel presents the negative
image of the TGF-1 (288 bp) and -actin (204 bp) PCR products run on a 3% w/v agarose gel and stained with ethidium bromide. Bottom panel
presents the mean ( SEM) ratio of TGF-1/-actin expression derived from densitometric scanning of the negative images from three experiments
performed with HPMC from separate donors. (B) Dose effect of increasing glucose concentrations on TGF-1 mRNA expression as assessed by
RT-PCR in growth-arrested HPMC. Top panel presents the negative image of the TGF-1 and -actin PCR products run on a 3% w/v agarose
gel and stained with ethidium bromide. Bottom panel presents the mean ( SEM) ratio of TGF-1/-actin expression derived from densitometric
scanning of the negative images from three experiments performed with HPMC from separate donors. (C ) Dose effect of increasing concentrations
of d-glucose ( ) or mannitol () on the induction of HPMC TGF-1 synthesis (pg/105 HPMC). Data presented are the mean ( SEM) from
three separate experiments performed with HPMC isolated from different donors. *Represents a statistically significant difference compared to
control (P  0.05). #Represents a statistically significant difference between equivalent glucose and mannitol concentrations (N  3, P  0.03
and 0.01 for 60 mmol/L and 100 mmol/L, respectively). (D) Time course of 60 mmol/L d-glucose ( ) or mannitol () induction of HPMC TGF-1
synthesis (pg/105 HPMC). Data presented are the mean ( SEM) from three separate experiments performed with HPMC isolated from different
donors. *Represents a statistically significant difference compared to the 1-hour time point (P  0.05). #Represents a statistically significant
difference between equivalent glucose and mannitol concentrations.
Effect of D-glucose on MCP-1 secretion of HPMC increased HPMC MCP-1 secretion in a dose-dependent
manner (1.3- and 1.9-fold increased compared with con-When HPMC was incubated with increasing concen-
trol at 60 mmol/L and 100 mmol/L mannitol, respec-trations of glucose (5 to 100 mmol/L) for 24 hours, there
tively) (N  7, P  0.01 for both). The effect of glucosewas a dose-dependant increase in MCP-1 secretion
was, however, significantly greater than that of mannitol.(Fig. 2C). MCP-1 (pg/105 HPMC) increased from 3543
At 60 mmol/L and 100 mmol/L d-glucose induced MCP-1286 in control (5 mmol/L d-glucose) and were 5028 
secretion was 1.3- and 1.4-fold greater than that induced424, 5911  729, and 8368  865 at 40 mmol/L, 60
by mannitol (N  7, P  0.05 for both) (Fig. 2D).mmol/L, and 100 mmol/L glucose, respectively (mean 
SEM, N  7, P  0.05 vs. control for all). Mannitol also d-Glucose and mannitol also induced a time-dependent
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Fig. 2. Time course of monocyte chemoattractant protein-1 (MCP-1) mRNA expression as assessed by reverse transcription-polymerase chain
reaction (RT-PCR) in growth-arrested human peritoneal mesothelial cells (HPMCs) exposed to increasing concentrations of D-glucose or mannitol.
(A) Representative negative image of the MCP-1 (369 bp) and -actin (204 bp) PCR products run on a 3% w/v agarose gel and stained with
ethidium bromide. (B) Mean ( SEM) ratio of MCP-1/-actin expression of glucose ( ) and mannitol () derived from densitometric scanning
of the negative images from three experiments performed with HPMC from separate donors. *Represents a statistically significant increase in the
MCP-1/-actin ratio compared to control (5 mM d-glucose). #Represents a significant difference between equivalent glucose and mannitol
concentrations. (C ) Dose effect of increasing concentrations of d-glucose ( ) or mannitol () on the induction of HPMC MCP-1 synthesis (pg/105
HPMC). Data presented are the mean ( SEM) from seven separate experiments performed with HPMC isolated from different donors. *Represents
a statistically significant difference compared to control (P  0.05). #Represents a statistically significant difference between equivalent glucose
and mannitol concentrations (N  3, P  0.03 and 0.01 for 60 mmol/L and 100 mmol/L, respectively). (D) Time course of 60 mmol/L d-glucose ( )
or mannitol () induction of HPMC MCP-1 synthesis (pg/105 HPMC). Data presented are the mean ( SEM) from three separate experiments
performed with HPMC isolated from different donors. *Represents a statistically significant difference compared to the 1-hour time point (P 
0.05). #Represents a statistically significant difference between equivalent glucose and mannitol concentrations.
increase of MCP-1 secretion; this increased synthesis cose above concentrations of 60 mmol/L (2.4-fold in-
crease at 60 mmol/L glucose compared to control). Abecame significant after 12 hours of exposure (for both
d-glucose and mannitol) and reached a plateau between similar pattern of increase was also observed with manni-
tol (5 to 100 mmol/L) (1.7-fold increase at 60 mmol/L24 and 48 hours (Fig. 2D).
mannitol compared to control). No effect was observed
Aldose reductase and sorbitol dehydrogenase mRNA on sorbitol dehydrogenase mRNA expression with in-
expression in HPMC creasing glucose or mannitol concentrations (results not
shown).Growth-arrested confluent HPMC were found to ex-
press aldose reductase and sorbitol dehydrogenase mRNA
Intracellular sorbitol accumulation in HPMCconstitutively in control medium with 5 mmol/L glucose.
Incubation with increasing concentrations of glucose (5 When incubated for 24 hours, a dose-dependent in-
crease in intracellular sorbitol accumulation was ob-to 100 mmol/L) resulted in a dose- and time-dependent
increase in aldose reductase mRNA expression (Fig. 3) served with increasing glucose concentrations (10 to 100
mmol/L). This increase became significant at 20 mmol/L(data not shown). This effect seemed to plateau at glu-
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Fig. 3. Time course of aldose reductase (AR)
mRNA expression as assessed by reverse tran-
scription-polymerase chain reaction (RT-PCR)
in growth-arrested human peritoneal meso-
thelial cells (HPMCs) exposed to increasing
concentrations of D-glucose or mannitol. Left
panel presents the mean ( SEM) ratio of
AR/-actin expression of glucose ( ) and man-
nitol () derived from densitometric scanning
of the negative images from three experiments
performed with HPMC from separate donors.
*Represents a statistically significant increase
in the AR/-actin ratio compared to control (5
mmol/L d-glucose). #Represents a significant
difference between equivalent glucose and
mannitol concentrations. Right panel presents
a representative negative image of the AR
(411 bp) and -actin (204 bp) PCR products
run on a 3% w/v agarose gel and stained with
ethidium bromide.
NaCl (5 to 60 mmol/L), however, resulted in only a
modest increase in intracellular sorbitol accumulation
(60 mmol/L NaCl 1.4-fold increase compared to control,
N  6, P  0.05). At all NaCl concentrations, sorbitol
levels were significantly lower than that induced by equi-
molar glucose concentrations (Fig. 4A). Since viability
of HPMC in 100 mmol/L NaCl fell below 80% of control,
data are only presented from HPMC exposed to concen-
trations up to 60 mmol/L.
The inhibition of aldose reductase activity in HPMCFig. 4. Time course of induction of intracellular sorbitol accumulation
[g/105 human peritoneal mesothelial cells (HPMCs)] in HPMC. (A) When HPMC where incubated for 24 hours with d-glu-
60 mmol/L d-glucose ( ) and sodium chloride (). Data presented are cose (60 mmol/L) intracellular sorbitol levels (expressedthe mean ( SEM) from three separate experiments performed with
in g/105 HPMC) were 10.17 2.6, a significant increaseHPMC isolated from different donors. *Represents a statistically sig-
nificant difference compared to the 1-hour time point (P 0.05). # Rep- compared to control (5 mmol/L d-glucose) (2.63  1.12,
resents a statistically significant difference between equivalent glucose N  3, P  0.05) (Fig. 5). The simultaneous presenceand mannitol concentrations (P  0.05). (B) Dose effect of increasing
of increasing concentrations of Sorbinil (1 to 100 mol/L)concentrations of d-glucose or sodium chloride (NaCl) on the induction
of HPMC intracellular sorbitol accumulation. Data presented are the resulted in intracellular sorbitol accumulation being re-
mean ( SEM) from six separate experiments performed with HPMC
duced in a dose-dependent manner. At the highest non-isolated from different donors. * Represents a statistically significant
difference compared to control (P  0.05). toxic concentration tested (100 mol/L), intracellular sor-
bitol concentration (expressed in g/105 HPMC) was
decreased to 4.19 1.9 (60 mmol/L d-glucose Sorbinil)
representing a 79.8% inhibition (N  3, P  0.01).glucose (1.6-fold increase compared to control) and
seemed to plateau at concentrations of glucose above 60
The effect of aldose reductase inhibition on TGF-1mmol/L (2.3-fold increase compared to control) (Fig.
secretion of HPMC4A). Exposure of HPMC to d-glucose (60 mmol/L) led
HPMC were incubated for 48 hours with control me-to a time-dependent increase in intracellular sorbitol ac-
dium (5 mmol/L d-glucose), 60 mmol/L d-glucose, or 60cumulation. This increase started from 3 hours postexpo-
mmol/L mannitol in the presence or absence of Sorbinilsure and became statistically significant after 12 hours
(10 to 100 mol/L). d-Glucose and mannitol significantly(7.9  0.84 g/105 HPMC, 2.2-fold increase compared
increased TGF-1 secretion compared to control [261 to 1 hour level, N  3, P  0.05). Intracellular sorbitol
33, 417  20, and 571  41 (pg/105 HPMC)] for control,levels further increased at 24 hours and were maximal
mannitol, and d-glucose, respectively (N 5, P 0.05 vs.after 48 hours (12.8 2.96, 3.6-fold increase, N  3, P 
control for both) (Fig. 6A). In the presence of sorbinil0.003) (Fig. 4B). Neither mannitol (nor l-glucose) could
(10 to 100 mol/L) the d-glucose induced secretion ofbe used as the osmotic control in these experiments as
TGF-1 was dose-dependently inhibited. At the highestit interfered directly with the sorbitol assay or caused
significant loss of cell viability. Exposure of HPMC to Sorbinil concentration used, d-glucose induced TGF-1
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cellular ATP levels (data not shown). Sorbitol induced
a dose-dependent increase in both TGF-1 and MCP-1
secretion. After 48 hours, TGF-1 (pg/105 HPMC) in-
creased from 280  17 in control (5 mmol/L d-glucose)
to 406  24 and 410  17 in 2 and 5 mmol/L sorbitol-con-
taining medium, respectively (N 4, P 0.002 5 mmol/L
sorbitol vs. control). MCP-1 levels (pg/105 HPMC) in-
creased from 5030  250 (in control) to 6187  380
and 6387  440 in 2 and 5 mmol/L sorbitol-containing
medium, respectively (N 4, P 0.03; 5 mmol/L sorbitol
vs. control).
Effect of sodium lactate and NaCl on TGF-1 and
Fig. 5. Dose effect of increasing concentrations of Sorbinil (1 to 100 MCP-1 secretion by HPMCmol/L) on 60 mmol/L D-glucose–induced intracellular sorbitol accumu-
lation in human peritoneal mesothelial cells (HPMCs). Data presented HPMC were incubated in the presence of 40 mmol/L
are the mean ( SEM) from three separate experiments performed
sodium lactate (pH 7.4) or 40 mmol/L NaCl as osmoticwith HPMC isolated from different donors. #Represents a statistically
significant difference compared to 60 mmol/L glucose alone (P  0.05). control. The viability of cells under both conditions was
Line represents a statistically significant increase compared to control greater than 95% of control (data not shown). At 48
(5 mmol/L d-glucose).
hours, TGF-1 secretion by HPMC was significantly
higher in 40 mmol/L lactate compared to that in 40
mmol/L NaCl (636  71, 426  36, and 300  29 for
sodium lactate, NaCl, and control, respectively) (N  5,secretion was inhibited by a mean of 44.2% (N  5, P 
P  0.02) (Fig. 7A). Sodium lactate–induced TGF-10.02 vs. 60 mmol/L d-glucose alone). The amount of
secretion (pg/105 HPMC) was suppressed by sorbinil inTGF-1 detected in the presence of 100 mol/L Sorbinil
a dose-dependent manner from 636  71 (40 mmol/Lwas not significantly different to that induced by 60
sodium lactate without sorbinil) to 457  26 (sodiummmol/L mannitol alone (60 mmol/L mannitol; 417  20
lactate with 100 mol/L Sorbinil) (47.8% inhibition, N  6,vs. 60 mmol/L d-glucose  100 mol/L sorbinil); 434 
P  0.02) (Fig. 7B). Sorbinil, irrespective of dose, did29 (pg/105 HPMC) (Fig. 6A). In parallel experiments,
not affect TGF-1 secretion induced by 40 mmol/L NaClmannitol-induced TGF-1 secretion was not reduced by
(Fig. 7C).the simultaneous presence of Sorbinil irrespective of
In parallel experiments, HPMC MCP-1 secretion (pg/dose (Fig. 6B).
105 HPMC) was increased by both NaCl and sodium
The effect of aldose reductase inhibition on MCP-1 lactate (4590  1030 and 5630  850 for 40 mmol/L
secretion of HPMC NaCl and sodium lactate, respectively) (N  6, P  0.02
NaCl vs. sodium lactate). In the presence of SorbinilIn these same experiments MCP-1 protein levels were
(100 mmol/L), sodium lactate–induced MCP-1 synthesisassessed. In the presence of sorbinil (10 to 100 mol/L),
was reduced to control levels (3667  578 vs. 3375 d-glucose–induced MCP-1 secretion (which was signifi-
578 for 40 mmol/L sodium lactate Sorbinil and control,cantly elevated over control, 3858 362) (pg/105 HPMC)
respectively).was dose dependently suppressed. At a sorbinil concen-
tration of 100 mol/L, MCP-1 levels (pg/105 HPMC) were
Modulation of TGF-1 and MCP-1 secretion byreduced from 6680 377 (60 mmol/L d-glucose) to 5236
sodium lactate and sodium pyruvate477 (d-glucose  Sorbinil) (mean 52.2% inhibition, N 
HPMC were incubated for 48 hours with 60 mmol/L5, P  0.05) (Fig. 6C). This level was not significantly
d-glucose in the presence or absence of sodium pyruvatedifferent to that induced by 60 mmol/L mannitol alone
(15 or 40 mmol/L) or sodium lactate (15 or 40 mmol/L).(4960  281). Mannitol-induced MCP-1 was not modi-
TGF-1 secretion (pg/105 HPMC) in 60 mmol/L d-glu-fied by the simultaneous presence of Sorbinil (Fig. 6D).
cose was 518  81 and increased to 618  57 and 692 
Influence of exogenous sorbitol on TGF-1 and MCP-1 88 in the presence of sodium lactate (15 and 40 mmol/L,
secretion by HPMC respectively) (N  4, P  0.05 for the latter) (Fig. 8).
In contrast in the presence of sodium pyruvate glucose-To confirm that products of the polyol pathway could
induced TGF-1 secretion were lower than glucoseactivate HPMC TGF-1 and MCP-1 synthesis, increas-
alone, 515  39 and 487  46 for 15 and 40 mmol/Ling concentrations of sorbitol (1 to 5 mmol/L) were
sodium pyruvate, respectively. The difference betweenadded to the culture medium. This addition was not
associated with a decrease in cell viability as assessed by glucose-induced TGF-1 secretion in the presence of 40
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Fig. 6. Dose effect of increasing concentra-
tions of Sorbinil (1 to 100 mol/L). (A) Dose
effect on 60 mmol/L d-glucose–induced trans-
forming growth factor-1 (TGF-1) synthesis
[pg/105 human peritoneal mesothelial cells
(HPMCs)] in HPMC. Data presented are the
mean ( SEM) from five separate experi-
ments performed with HPMC isolated from
different donors. *Represents a statistically
significant difference compared to 60 mmol/L
glucose alone (P  0.02). (B) Dose effect on
60 mmol/L mannitol-induced TGF-1 synthe-
sis in HPMC. Data presented are the mean
( SEM) from five separate experiments per-
formed with HPMC isolated from different
donors. None of the differences are statisti-
cally significant. (C ) Dose effect on 60 mmol/L
d-glucose–induced monocyte chemoattractant
protein-1 (MCP-1) synthesis (pg/105 HPMC)
in HPMC. Data presented are the mean
( SEM) from five separate experiments per-
formed with HPMC isolated from different
donors. *Represents a statistically significant
difference compared to 60 mmol/L glucose
alone (P 0.05). (D) Dose effect on 60 mmol/L
mannitol-induced MCP-1 synthesis in HPMC.
Data presented are the mean ( SEM) from
five separate experiments performed with
HPMC isolated from different donors. None
of the differences are statistically significant.
Fig. 7. Dose effect on the induction of trans-
forming growth factor-1 (TGF-1) synthesis
[pg/105 human peritoneal mesothelial cells
(HPMCs)]. (A) Effect of 5 mol/L glucose, 40
mmol/L sodium chloride (NaCl), and sodium
lactate (Na Lactate). Data presented are the
mean ( SEM) from five separate experi-
ments performed with HPMC isolated from
different donors. *Represents a statistically
significant difference compared to control (5
mmol/L) glucose (P  0.05). #Represents a
statistically significant difference (P  0.019)
between NaCl and Na Lactate. (B) Dose effect
of increasing concentrations of Sorbinil (1 to
100 mol/L) on 40 mmol/L Na Lactate. (C )
Dose effect of increasing concentrations of 40
mmol/L NaCl and Sorbinil. Data presented
are the mean ( SEM) from five separate
experiments performed with HPMC isolated
from different donors. *Represents a statisti-
cally significant difference compared to con-
trol 40 mmol/L Na Lactate alone (P  0.05).
Line represents a statistically significant in-
crease (P  0.05).
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components is lacking [37–40]. Among these compo-
nents glucose has been widely suggested as a key factor
contributing to structural and functional alterations to
the peritoneal membrane [41]. Part of this evidence re-
lates to morphological studies of the peritoneal mem-
brane that have identified vascular alterations similar to
those described for diabetic microangiopathy [6, 7].
Previous studies examining the impact of glucose on
mesothelial cell function have identified that both glu-
cose-specific and osmolality-dependent effects contrib-
ute to changes in cell viability and function [12, 13,
42–47]. To date, however, the mechanisms controlling
these diverse effects on mesothelial cell function have
not been fully elucidated.
Fig. 8. Effect of 60 mmol/L D-glucose alone or in the presence of The polyol pathway has been implicated in glucose-
sodium lactate (L) or sodium pyruvate (P) on human peritoneal meso- related tissue damage in diabetic mellitus [22, 48]. At
thelial cells (HPMC) transforming growth factor-1 (TGF-1) synthesis
physiologic glucose concentrations, the majority of the(pg/105 HPMC). Data presented are the mean ( SEM) from four
separate experiments performed with HPMC isolated from different cellular glucose is phosphorylated to glucose-6-phospha-
donors. Line represents a statistically significant increase compared to tase by hexokinase. Only a minor part of the nonphos-
control (5 mmol/L d-glucose) (P  0.05). * Represents a statistically
phorylated glucose enters the polyol pathway. The rate-significant difference between d-glucose  40 mmol/L sodium lactate
and d-glucose  40 mmol/L sodium pyruvate (P  0.03). limiting step of this pathway is the reduction of glucose
to sorbitol catalyzed by aldose reductase. Sorbitol is sub-
sequently converted to fructose by sorbitol dehydroge-
nase, which is coupled to reduction of NAD to NADH.
mmol/L sodium lactate and sodium pyruvate was statisti- When exposed to high glucose concentrations, saturation
cally significant (N  4, P  0.008). of hexokinase occurs, and the influx of glucose through
In these same experiments, MCP-1 levels (pg/105 the polyol pathway increases and may account for as
HPMC) were increased from 3941  564 in control to much as one third of the total glucose turnover [49, 50].
5665  674 and 7133  853 in the presence of d-glucose Aldose reductase and sorbitol dehydrogenase levels
(60 mmol/L) or NaCl (40 mmol/L), respectively (N  4, vary between different tissues and thus might contribute
P  0.05 for both). In the presence of sodium lactate to their susceptibility to glucose-mediated damage. In
d-glucose–induced MCP-1 secretion increased to 8153  the present study we identified that both aldose reduc-
1043 and 9143  1064 for 15 mmol/L and 40 mmol/L tase and sorbitol dehydrogenase mRNA are expressed
sodium lactate, respectively (N  4, P  0.05 for both). constitutively in HPMC. Moreover, aldose reductase
In the presence of sodium pyruvate MCP-1 levels were mRNA expression increased in response to increasing
not significantly different to that induced by glucose glucose concentrations. Expression of sorbitol dehydro-
alone (6215  764 and 6312  695) for 15 mmol/L and genase mRNA expression was, however, not altered by
40mmol/L sodium pyruvate, respectively. The difference glucose, which is similar to findings in medullary collect-
between glucose-induced MCP-1 secretion in the pres- ing duct cells [21]. In parallel with these changes in aldose
ence of 40 mmol/L sodium lactate and sodium pyruvate reductase mRNA expression, intracellular sorbitol accu-
was statistically significant (N  4, P  0.04). mulation increased with increasing glucose concentra-
tions. These data confirm the activation of the polyol
pathway occurs under conditions paralleling those found
DISCUSSION
in the peritoneal cavity during dialysis.
The mesothelial layer through its ability to express a In parallel experiments d-glucose also induced a concen-
large number of biologically active molecules plays a tration-dependent up-regulation of TGF-1 and MCP-1
central role in maintaining peritoneal homeostasis [36]. mRNA expression and protein secretion. The observed
During peritoneal dialysis, however, the peritoneal mem- increases in MCP-1 and TGF-1 protein synthesis were
brane is exposed to both inflammation and to unphysio- in the case of d-glucose preceded by induction of specific
logic dialysis solutions that can alter mesothelial cell mRNA transcripts. Although the increases in TGF-1
metabolism and which might contribute to long-term mRNA were not substantial, that a significant increase
alterations in membrane structure and function [7, 9]. occurred was confirmed by quantitative PCR. The level
Although both in vitro and recent ex vivo evidence sug- of increase observed (one- to threefold) does, however,
gesting that dialysis solutions can modulate cell function, concur with previous observations on HPMC TGF-1
mRNA induction by glucose [13, 45]. In the case ofdirect in vivo evidence implicating individual solution
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mannitol, our experiments revealed no significant change mechanism, however, appears to play an important role
in HPMC activation by glucose.in TGF-1 mRNA. TGF-1 mRNA levels were, how-
ever, constitutively highly expressed in control HPMC, That osmolality per se can activate mesothelium con-
firms previous observations [14, 44]. In vitro effects ofdata, which confirm previous studies suggesting that both
transcriptional and posttranscriptional mechanisms con- hyperosmolality leading to suppression of cell prolifera-
tion and induction of morphologic changes have beentrol of TGF-1 protein production [51, 52].
That this induction process was at least partly medi- demonstrated in HPMC [60, 61]. In SV40-transformed
HPMC, hyperosmolality suppressed the expression ofated by activation of the polyol pathway (and related to
intracellular sorbitol accumulation) was confirmed by MMP9 that favored the accumulation of type IV collagen
[14]. Data on the effect of hyperosmolaltiy on TGF-1specific inhibition of both TGF-1 and MCP-1 synthesis
by the aldose reductase inhibitor Sorbinil. At the same production by HPMC is, however, variable. In the study
by Kang et al [13], no effect of mannitol on TGF-1concentrations Sorbinil was able to completely inhibit
the d-glucose–driven accumulation of intracellular sorbi- mRNA or protein production was observed. While we
were able to confirm the lack of induction of TGF-1tol in HPMC. This mechanism is further supported by
the experiments in which exogenous sorbitol was added mRNA by mannitol, we were able to detect both dose-
and time-dependent increases in TGF-1 protein secre-to HPMC cultures, resulting in the induction of both
TGF-1 and MCP-1 synthesis. tion. These data confirm recently published observations
where mannitol was able to dose-dependently induceIntracellular sorbitol accumulation per se can modu-
late cell responsiveness (see below). One of the other TGF-1 secretion by HPMC [44].
The exact mechanism by which hyperosmolality acti-possible consequences of greater intracellular sorbitol
accumulation is its increased conversion to fructose by vates cellular function of HPMC has not been defined.
In other cell systems it has been shown that on exposuresorbitol dehydrogenase (which is highly constitutively
expressed in HPMC) and a concomitant increase in the to hypertonic medium, intracellular osmolytes, including
myoinositol, sorbitol, betaine, and glycerophosphoryl-NADH/NAD ratio. This altered redox ratio has also
been implicated in cellular dysfunction [22]. It can en- choline accumulate in order to restore cellular volume
[62]. In addition, exposure of cells to hyperosmolalityhance the formation of de novo diacylglycerol (DAG).
DAG is a regulatory stimulator of protein kinase C results in the activation of a number of signaling cascades
leading to phosphorylation of mitogen-activated protein(PKC) and its elevation is the presumed mechanism for
the elevated PKC activity observed in several tissues kinases (including p38 and Jnk) and downstream tran-
scription factor activation [63, 64]. These processes areafter exposure to high glucose concentrations [53–58].
In the renal mesangial cells, glucose activation of PKC clearly involved in cell activation, whether these or simi-
lar mechanisms are activated in HPMC by osmolalityand TGF-1 synthesis is polyol pathway dependent [53,
55–57]. Recent data confirm that a similar PKC-depen- requires further study.
In addition to high concentrations of glucose, conven-dent mechanism contributes to TGF-1 and MCP-1 syn-
thesis in HPMC, whether this activation is mediated by tional dialysate solutions contain high concentrations of
sodium lactate. Previous data have identified that in com-flux through the polyol pathway, however, remains to
be determined [45, 59]. bination with the initial acid pH of these solutions, lactate
can significantly modulate cell function largely as a resultIn experiments where HPMC were exposed to manni-
tol (or NaCl) there were also time- and dose-dependent of rapid intracellular acidification [65–67]. The pH of
infused dialysis solutions is rapidly neutralized in vivo,increases in both TGF-1 and MCP-1 expression, albeit
at lower levels than that induced by equivalent d-glucose both glucose and lactate concentrations, however, re-
main elevated for the majority of the dialysis cycle [68].concentrations. In parallel experiments NaCl also induced
intracellular sorbitol accumulation, although again the Previous data have suggested that lactate can enhance
the inhibitory effects of glucose on mesothelial cell func-increase was of a much lower magnitude than that in-
duced by glucose. These data suggest that while d-glucose– tion [23, 69]. The importance of lactate-driven intracellu-
lar sorbitol accumulation rather than downstream eventsdriven polyol pathway activation (and intracellular sorbi-
tol accumulation) contributes significantly to HPMC as a mechanism of HPMC activation is supported by
experiments in which lactate either alone or in conjunc-TGF-1 and MCP-1 expression, osmolality-driven events
also contribute to HPMC activation. While part of this tion with glucose augmented HPMC activation which
was inhibitable by Sorbinil. Exposure of HPMC to glu-effect may be related to osmolality-driven activation of
polyol pathway activation (as evidenced by the ability cose in the presence of lactate resulted in an induction
of both of TGF-1 and MCP-1 synthesis above the levelsof NaCl to increase intracellular sorbitol concentrations),
the small increases induced by NaCl suggest that this induced by glucose or lactate alone. In contrast, in the
presence of pyruvate their levels remained unaltered orplays a major role in osmolality-driven HPMC activation.
A polyol pathway–independent osmolality-dependent were reduced. These data suggest, in agreement with
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2. Struijk DG, Krediet RT, Koomen GC, et al: Functional character-previous studies [23], that while lactate serves to enhance
istics of the peritoneal membrane in long-term continuous ambula-
glucose mediated modulation of cell function, possibly tory peritoneal dialysis. Nephron 59:213–220, 1991
3. Slater ND, Cope GH, Raftery AT: Mesothelial hyperplasia invia enhanced activation of the polyol pathway and sorbi-
response to peritoneal dialysis fluid: A morphometric study in thetol accumulation, pyruvate may act in an opposite or
rat. Nephron 58:466–471, 1991
antagonistic manner. The mechanism by which this oc- 4. Honda K, Nitta K, Horita H, et al: Morphological changes in the
peritoneal vasculature of patients on CAPD with ultrafiltrationcurs in HPMC remains to be fully determined, it is known,
failure. Nephron 72:171–176, 1996however, that lactate favors sorbitol accumulation (pos-
5. Honda K, Nitta K, Horita S, et al: Accumulation of advanced
sibly by decreasing its conversion to fructose as a result glycation end products in the peritoneal vasculature of continuous
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